Streetbeat News

Revenues

GVA

Granite Construction reported better-than-expected Q3 financial results and issued FY23 revenue guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 2:52 pm

SHOP

Traders are circulating negative analyst comments about Shopify (SHOP), suggesting that they are expecting the company's revenues to fall below consensus.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 1:38 pm

SPY

According to Redbook, U.S. retail sales for the first four weeks of October increased by 4.7% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:58 pm

SPY

USA Redbook Retail Sales report shows a 5.3% increase for the week ending October 28 compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:58 pm

CHGG

Chegg reported Q3 financial results, issued Q4 guidance, and announced a 4% YoY decrease in Q3 Subscription Services revenues. This news led to a drop in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:46 pm

CAT

Caterpillar's executive has stated that the company is witnessing continued growth in non-residential construction in North America. However, the CEO also noted a reduction in dealer orders for construction products, which was anticipated.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:44 pm

TFIN

UPS

Coyote Logistics, a UPS company, has joined the TriumphPay payments network. This partnership will allow Coyote to offer its carriers a seamless and integrated payment experience.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:44 pm

EVOK

Evoke Pharma (NASDAQ:EVOK) and EVERSANA have presented real-world data demonstrating that GIMOTI, a nasal spray for treating diabetic gastroparesis (DGP), reduces healthcare costs compared to oral metoclopramide. The data, presented at the American College of Gastroenterology 2023 Annual Meeting, shows that DGP patients treated with GIMOTI were less likely to visit the emergency department or be admitted to the hospital. Over a six-month period, GIMOTI patients spent approximately $15,000 less than those on oral metoclopramide.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:42 pm

SPY

The Employment Cost Index for Q3 has come in at 1.1%, slightly above the estimated 1%.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:30 pm

AAPL

HNHPF

Foxconn Technology Group is expected to have a strong October due to orders for Apple's M3-powered new MacBook Pro and iMac. Foxconn is also responsible for components such as chassis.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:15 pm